Hexarad Competitive Intelligence & Landscape

Hexarad is a UK-based healthcare technology company specializing in teleradiology and digital radiology solutions. Founded in 2016 and headquartered in London, England, Hexarad focuses on providing fast, accurate diagnosis services through its innovative tele-radiology platform, which supports remote reporting of medical scans such as CTs, MRIs, and X-rays (Hexarad). The company was established by consultant radiologists who understand the inherent challenges of radiology and aim to improve patient outcomes by ensuring timely diagnoses (Result 4).

Hexarad's core products include an award-winning tele-radiology platform that leverages AI-enhanced solutions for scan assignment and report generation, helping healthcare providers increase efficiency and reduce turnaround times. The company serves over 50 sites across the UK and Ireland, offering its services to hospitals, diagnostics centers, and healthcare providers. Its mission is to deliver fast and accurate diagnosis for everyone, everywhere, emphasizing clinical excellence, innovation, and patient-centered care (Result 4, Result 6).

With a workforce of approximately 87 employees, Hexarad has experienced significant growth, including a recent Series B funding round of around $14.4 million in August 2024, which supports its expansion and development efforts. The company also engages in academic and industry collaborations, such as partnerships with NHS foundations and launching professional development fellowships, to foster innovation and improve radiology services (Result 6, Result 7). Overall, Hexarad aims to revolutionize radiology through technology, expertise, and a patient-focused approach.

Hexarad offers a comprehensive radiology platform that integrates AI-enhanced solutions to improve diagnostic accuracy and workflow efficiency. While specific current pricing plans and tiers are not explicitly detailed in the available sources, Hexarad's platform is known to provide cost-saving benefits, such as saving hospitals up to £365,000 annually on locum fees by reducing waiting times and optimizing radiology workflows (buildingbetterhealthcare.com).

Hexarad's AI-powered features include intelligent triage, automatic scan matching to subspecialists, and real-time alerts for critical cases, which collectively enhance reporting speed and quality (hexarad.com/ai). The platform also offers tools like report generation software and scan assignment solutions, with recent updates focusing on improving turnaround times in acute care settings (hexarad.com/reportrad).

Although precise details about free versus paid features or tiered subscription models are not specified, Hexarad's recent funding and strategic growth indicate a scalable SaaS model aimed at large hospital groups and diagnostics centers. Their solutions are designed to be adaptable for enterprise deployment, with a focus on expanding AI integration and workflow optimization services (leadiq.com).

Hexarad, a London-based health technology startup specializing in teleradiology software, has recently secured significant funding to support its growth and expansion efforts. In August 2024, Hexarad raised £11 million (approximately $14.2 million) in a funding round led by MTIP, a Swiss growth equity firm, with additional contributions from existing shareholders (The BAE HQ, Medium). This investment underscores Hexarad’s strategic focus on expanding its innovative platform, which aims to reduce radiology delays within the NHS and other healthcare systems by automating and streamlining radiology workflows (LeadIQ).

In terms of hiring trends, Hexarad is actively recruiting, with current job listings indicating a focus on roles in technology, healthcare, and operations, reflecting a growth-driven strategy. The company employs around 63 staff members and has a culture centered on innovation and healthcare impact (Built In). Their hiring pattern suggests a focus on expanding technical and clinical teams to support product development, customer service, and strategic partnerships. The company's recent funding and hiring activity signal a strong growth trajectory and a commitment to scaling their AI-enhanced radiology solutions, which could position Hexarad as a leader in digital health and radiology services in the near future.

Hexarad is a London-based health technology company that has demonstrated strong financial growth through recent funding rounds. In August 2024, Hexarad secured £11 million in funding, led by the Swiss growth equity firm MTIP, with additional support from existing shareholders such as the Foresight Group (thebaehq.com). This funding is aimed at expanding its proprietary teleradiology platform, which is designed to improve workflow efficiency and reduce delays in radiology departments, especially within the NHS. Although specific revenue figures and valuations are not publicly disclosed, the significant investment indicates strong investor confidence and positive financial health. The company's focus on automating and streamlining radiology processes positions it well for continued growth in the healthcare tech sector, particularly in markets facing radiologist shortages and increasing demand for efficient diagnostic services. There is no publicly available information about recent M&A activity involving Hexarad, suggesting the company is currently focused on organic growth and platform expansion.

Hexarad actively participates in various events related to radiology and global health initiatives. Notably, Hexarad collaborates with RAD-AID International through the RAD-AID Hexarad Global Radiology Program, which involves international projects aimed at improving access to radiology services in underserved regions (RAD-AID). While specific conferences, trade shows, webinars, or community events hosted or attended by Hexarad are not explicitly listed in the search results, their involvement in the RAD-AID program indicates participation in global health and radiology-focused initiatives.

The RAD-AID Hexarad program itself encompasses activities such as training, project planning, and implementation in low-resource settings, which likely include webinars, training sessions, and community engagement events as part of their ongoing efforts (RAD-AID). Given the nature of such collaborations, Hexarad’s event participation probably extends to international radiology conferences, health tech trade shows, and webinars aimed at advancing global radiology education and infrastructure, although specific events are not detailed in the current search results.